Legal Status of Peptides in Estonia (2026)
Research peptides are legal to purchase in Estonia for scientific and research purposes. Under the Estonian Medicinal Products Act (Ravimiseadus), compounds sold strictly for research and not marketed as medicines fall outside the authorisation regime overseen by the State Agency of Medicines (Ravimiamet).
Common research peptides — BPC-157, TB-500, CJC-1295, Ipamorelin, GHK-Cu, Glutathione, NAD+ — are not listed as controlled substances under Estonian drug law, and no import permit is required for intra-EU transfers from another member state.
Ravimiamet Scope and EU Intra-Community Transfer
Ravimiamet's remit covers medicinal products placed on the Estonian market. Research peptides are not placed on the market as medicines — they are supplied to laboratories with research-only labelling, a Certificate of Analysis, and no therapeutic claims. ORYN's Netherlands dispatch hub treats Estonia shipments as intra-EU transfers, which means no customs clearance, no import duty, and no Estonian VAT added at the door.
AVAILABLE PEPTIDE PENS
Delivery to Estonia — Omniva and DPD
ORYN delivers peptide pens across Estonia in 3–5 business days via Omniva and DPD Estonia. Tallinn, Tartu, Narva, and Parnu receive shipments in 3 business days; addresses in Hiiumaa or Saaremaa islands add 1–2 days. DHL Express is available on request for 2-day priority service.
Delivery details: - Free shipping over EUR 175 - Cold-chain insulated packaging - Plain outer box with no product descriptors - COA and research-use declaration enclosed